+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-drug resistance and cancer therapies

Multi-drug resistance and cancer therapies

Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S47, June

(PDF 0-2 workdays service: $29.90)

Accession: 035349139

Download citation: RISBibTeXText

Related references

Ara-C Is Not a Substrate for the Breast Cancer Resistance Protein and Multi Drug Resistance Proteins Do Not Play a Significant Role in Drug Resistance in Infant Acute Lymphoblastic Leukemia. Blood 100(11): Abstract No 4356, November 16, 2002

Differential sensitivity of multi drug resistant and multi drug sensitive cells to resistance modifying agents and the relation with reversal of anthracycline resistance. International Journal of Cancer 46(2): 330-336, 1990

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids and Surfaces. B, Biointerfaces 110: 74-80, 2014

Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?. Drug Discovery Today 17(9-10): 435-442, 2012

Developing combinatorial multi-component therapies (CMCT) of drugs that are more specific and have fewer side effects than traditional one drug therapies. Nonlinear Biomedical Physics 1(1): 11-11, 2007

Breast cancer resistance protein ABCG2 A novel member of ABC transporter superfamily involved in multi-drug resistance. Acta Haematologica Polonica 33(4): 403-416, 2002

Adjuvant chemo therapy with inductive multi drug combination and long term oral maintenance therapies for gastric cancer. Journal of Japan Society for Cancer Therapy 15(6): 980-988, 1980

A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer. Plos One 11(9): E0162407-E0162407, 2016

A New Era for Cancer Target Therapies: Applying Systems Biology and Computer-Aided Drug Design to Cancer Therapies. Current Pharmaceutical Biotechnology (): -, 2016

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials 32(30): 7711-7720, 2011

Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro. Zhonghua Fu Chan Ke Za Zhi 44(9): 686-690, 2011

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy 18(6): 831-836, 2015

Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impact of multi-drug resistance. Infectious Diseases 48(6): 428-431, 2016

Heat shock do not promote multi-drug resistance but sensitise oesophageal cancer cells when exposed to anti-cancer drugs. Anticancer Research 18(6C): 4924-4925, 1998

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World Journal of Hepatology 2(3): 114-126, 2010